ロード中...
Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
Lung cancer is the leading cause of cancer death, and approximately 15% of all lung cancer patients have small-cell lung cancer (SCLC). Although second-line chemotherapy can produce tumor regression, the prognosis is poor. Amrubicin hydrochloride (AMR) is a synthetic anthracycline anticancer agent a...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Libertas Academica
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3076041/ https://ncbi.nlm.nih.gov/pubmed/21499556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S5072 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|